Serious Side Effects Linked to Nuplazid® (pimavanserin)
- Ellis B, Hicken M. FDA worried drug was risky; now reports of deaths spark concern. CNN. Available at https://www.cnn.com/2018/04/09/health/parkinsons-drug-nuplazid-invs/index.html. Accessed 4/12/18.
- Nuplazid prescribing information. Available at https://www.nuplazid.com/pdf/NUPLAZID_Prescribing_Information.pdf. Accessed 4/12/18.
- Tedeschi B. New Parkinson’s drug could reduce hallucinations, but at what cost? STAT. Available at https://www.statnews.com/2016/03/28/parkinsons-psychosis-nuplazid/. Accessed 4/12/18.
- What is a serious adverse event? U.S. Food & Drug Administration. Available at https://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm. Accessed 4/12/18.
- Safety Signals for Two Novel Drugs. Institute for Safe Medication Practices. Available at https://www.ismp.org/sites/default/files/attachments/2018-01/2017Q1_0.pdf. Accessed 4/12/18.
- FDA Adverse Events Reporting System Public Dashboard. Available at https://fis.fda.gov/sense/app/777e9f4d-0cf8-448e-8068-f564c31baa25/sheet/45beeb74-30ab-46be-8267-5756582633b4/state/analysis. Accessed 4/12/18.